STOCK TITAN

Definitive Healthcare Corp. - DH STOCK NEWS

Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.

About Definitive Healthcare Corp. (DH)

Definitive Healthcare Corp. (Nasdaq: DH) is a leading provider of healthcare commercial intelligence, delivering actionable data and insights to organizations across the healthcare ecosystem. The company's mission is to transform data, analytics, and expertise into meaningful intelligence that enables its clients to uncover opportunities, optimize strategies, and drive growth. By leveraging a robust SaaS-based platform, Definitive Healthcare empowers clients to navigate the complexities of the healthcare market with precision and confidence.

Comprehensive Data and Analytics Platform

At the core of Definitive Healthcare's offerings is its proprietary platform, which aggregates and analyzes data on over 8,100 hospitals, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 accountable care organizations (ACOs) and health information exchanges (HIEs), 197,000 physician groups, 1.3 million physicians, and 750 Canadian hospitals. This extensive dataset provides clients with unparalleled visibility into the healthcare provider landscape, enabling them to make informed decisions in areas such as market segmentation, sales execution, and product development.

Key Solutions and Products

  • Monocl ExpertInsight: A comprehensive tool that delivers data on more than 15 million medical experts globally, helping pharmaceutical and medtech companies enhance Key Opinion Leader (KOL) engagement and clinical collaboration.
  • Population Intelligence: Combines clinical and consumer data to enable precision marketing, allowing businesses to identify and target specific audience segments effectively.
  • Carevoyance: A solution tailored for medtech sales teams, providing deep insights into provider segmentation, territory alignment, and sales tracking to streamline workflows and accelerate device adoption.
  • Market Forecast: A predictive analytics tool that offers three, five, and ten-year market trend projections, helping healthcare organizations plan strategically for future demand and growth opportunities.
  • DH View Suite: A mobile-enabled platform that equips sales and marketing teams with instant access to critical intelligence on healthcare professionals and organizations, enhancing productivity and client engagement.
  • Monocl Conferences: A specialized solution for life sciences organizations to optimize conference planning and participation, providing insights into key presentations, trending topics, and expert engagement opportunities.

Market Position and Competitive Landscape

Operating within the rapidly evolving healthcare data analytics industry, Definitive Healthcare stands out for its depth of data, innovative solutions, and focus on healthcare-specific use cases. Its competitors include companies like IQVIA and Truveta, but Definitive Healthcare differentiates itself through its tailored SaaS offerings and the integration of predictive analytics with real-time data visualization. The company's solutions address critical challenges faced by healthcare organizations, such as identifying high-growth markets, optimizing sales territories, and enhancing patient engagement strategies.

Revenue Model and Geographic Focus

Definitive Healthcare generates the majority of its revenue through subscription-based services, offering scalable solutions that cater to organizations of all sizes. While its primary market is the United States, the company also provides data on international healthcare providers, particularly in Canada, further broadening its client base and market reach.

Challenges and Opportunities

As a data-centric organization, Definitive Healthcare faces challenges such as ensuring the accuracy and comprehensiveness of its datasets, navigating complex regulatory environments, and mitigating cybersecurity risks. However, its investments in proprietary data science, AI-driven analytics, and user-friendly interfaces position it well to address these challenges and capitalize on growing demand for healthcare intelligence solutions.

Conclusion

Definitive Healthcare Corp. is a pivotal player in the healthcare commercial intelligence space, enabling organizations to unlock new opportunities and optimize their operations through data-driven insights. With its diverse product portfolio, deep industry expertise, and commitment to innovation, Definitive Healthcare continues to shape the future of the healthcare market, providing clients with the tools they need to succeed in an increasingly competitive landscape.

Rhea-AI Summary

Definitive Healthcare reported a 7% increase in revenue to $63.5 million for the first quarter of fiscal year 2024. The company's adjusted EBITDA and net income also showed positive growth compared to the same period last year. Definitive Healthcare expanded its enterprise customer base and made significant customer wins. The Board of Directors approved a stock repurchase program of up to $20.0 million. The company issued financial guidance for the second quarter and full year 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.21%
Tags
-
Rhea-AI Summary
Definitive Healthcare Corp. (DH) will report its Q1 2024 financial results on May 7, 2024, after market close. The conference call and webcast to discuss the results will be held at 5:00 PM (ET) / 2:00 PM (PT). Investors can access the live webcast on the company's Investor Relations website. A replay will be available until June 6, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
-
Rhea-AI Summary
Definitive Healthcare launches Carevoyance sales enablement solution for medtech industry, offering streamlined workflows and data-driven insights to accelerate sales cycles and improve targeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.1%
Tags
none
Rhea-AI Summary
Definitive Healthcare (Nasdaq: DH) and VML Health form a groundbreaking partnership to streamline engagement between pharmaceutical companies and key opinion leaders (KOLs), enhancing clinical collaborations globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.79%
Tags
partnership
-
Rhea-AI Summary
Definitive Healthcare (DH) has been named one of the Boston Business Journal’s Middle Market Leaders for 2024, showcasing significant revenue growth from 2020 to 2022. The company's total revenue increased from $118.3 million to $222.7 million during this period, marking a 34% year-over-year growth. Definitive Healthcare's recognition highlights its commitment to providing valuable healthcare commercial intelligence and its strong financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
none
-
Rhea-AI Summary
Definitive Healthcare Corp. reported a 9% increase in fourth-quarter revenue to $65.9 million and a 13% increase in full-year revenue to $251.4 million in 2023. The company also announced customer wins and financial guidance for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
Rhea-AI Summary
Definitive Healthcare Corp. will report financial results for Q4 and full year 2023 on February 28, 2024. The company will host a conference call to discuss the results. Investors can access the live webcast or dial-in for the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.76%
Tags
-
Rhea-AI Summary
Definitive Healthcare (Nasdaq: DH) announced the appointment of Jason Krantz as interim CEO, following the departure of Robert Musslewhite. The company reaffirmed its Q4 2023 financial guidance and issued preliminary guidance for 2024, expecting revenue to grow 5-7% and adjusted EBITDA margin to increase by approximately 200 basis points. The leadership transition aims to position the organization for further growth, with Mr. Krantz expressing confidence in the company's potential for long-term value creation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.58%
Tags
none
-
Rhea-AI Summary
Datassential's former CEO, Jim Emling, has been appointed Executive Chair of the Board of Directors at VBA, a company heavily investing in sales and product development after closing a growth equity transaction led by Spectrum Equity and Arthur Ventures. VBA serves the entire payer landscape, including third party administrators (TPAs) and health plans, with its next-gen Core Administrative Processing System, user engagement platforms, customer support tools, population health reporting solution, and robust data connections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary
Definitive Healthcare has announced the hiring of Carrie Lazorchak as its new Chief Revenue Officer. As part of her employment agreement, Lazorchak has been granted 385,695 time-based restricted stock units (RSUs) effective November 1, 2023. The RSUs will vest over a 4-year period, with 25% vesting on the 1-year anniversary of the grant date and the remainder vesting in quarterly installments over the subsequent 3 years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
none

FAQ

What is the current stock price of Definitive Healthcare (DH)?

The current stock price of Definitive Healthcare (DH) is $2.83 as of March 3, 2025.

What is the market cap of Definitive Healthcare (DH)?

The market cap of Definitive Healthcare (DH) is approximately 348.9M.

What does Definitive Healthcare Corp. do?

Definitive Healthcare provides healthcare commercial intelligence through its SaaS platform, offering data and analytics on healthcare providers to help clients optimize strategies and drive growth.

What industries does Definitive Healthcare serve?

The company serves a wide range of industries, including pharmaceuticals, medtech, healthcare providers, and life sciences organizations.

How does Definitive Healthcare generate revenue?

Definitive Healthcare primarily generates revenue through subscription-based services, offering scalable solutions for its clients.

What are some of Definitive Healthcare's key products?

Key products include Monocl ExpertInsight, Population Intelligence, Carevoyance, Market Forecast, DH View Suite, and Monocl Conferences.

What makes Definitive Healthcare unique in its industry?

The company stands out for its comprehensive datasets, healthcare-specific solutions, and integration of predictive analytics with real-time data visualization.

Who are Definitive Healthcare's competitors?

Competitors include IQVIA, Truveta, and other healthcare data analytics providers, though Definitive Healthcare differentiates itself through its tailored SaaS offerings and depth of data.

What challenges does Definitive Healthcare face?

Challenges include maintaining data accuracy, navigating regulatory compliance, and addressing cybersecurity risks.

What geographic regions does Definitive Healthcare cover?

While the company focuses primarily on the United States, it also provides data on Canadian healthcare providers and other international markets.

What is Monocl ExpertInsight?

Monocl ExpertInsight is a tool that provides data on over 15 million medical experts globally, helping clients enhance Key Opinion Leader (KOL) engagement.

How does Population Intelligence benefit businesses?

Population Intelligence combines clinical and consumer data to enable precision marketing, helping businesses identify and target specific audience segments effectively.
Definitive Healthcare Corp.

Nasdaq:DH

DH Rankings

DH Stock Data

348.90M
43.86M
3.85%
95.31%
1.82%
Health Information Services
Services-prepackaged Software
Link
United States
FRAMINGHAM